Testing a new drug in healthy volunteers
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are in good general health, with no serious medical conditions.
- Your body mass index (BMI) is between 18.0 and 32.0.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control if needed.
- You are not taking any medications (except for occasional pain relievers or vitamins) in the 2 weeks before the study.
- You do not smoke more than 5 cigarettes a day and can stop smoking during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.
This study tests a new medicine called INS1033 in healthy people to see if it is safe and how the body handles it. It is an early-stage study and does not involve treating any disease.
This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.
This study tests a new tablet called VV261 in healthy volunteers. It looks at how the drug moves through the body and how safe it is when taken multiple times. It may help show if the drug is promising for future treatments.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.